Laborie Medical Technologies, Inc., headquartered in California, is a leading innovator in the medical technology industry, specialising in urology and gastroenterology solutions. Founded in 1967, the company has established a strong presence in North America, Europe, and Asia, providing advanced diagnostic and therapeutic products that enhance patient care. With a diverse portfolio that includes urodynamics, pelvic floor therapy, and gastrointestinal diagnostics, Laborie is recognised for its commitment to quality and innovation. Their unique offerings, such as the advanced bladder scanner and comprehensive urodynamic systems, set them apart in a competitive market. Laborie's dedication to research and development has earned it a prominent position within the industry, making significant strides in improving clinical outcomes and patient experiences. As a trusted partner for healthcare professionals, Laborie continues to shape the future of medical technology.
How does Laborie Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laborie Medical Technologies, Inc.'s score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Laborie Medical Technologies, Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Laborie Medical Technologies appears to be in the early stages of establishing its climate commitments. Without emissions data or reduction initiatives, it is unclear how the company plans to address its environmental impact or align with industry standards for sustainability. In the context of the medical technology sector, companies are increasingly expected to adopt robust climate strategies, including setting science-based targets and committing to transparency in emissions reporting. Laborie Medical Technologies may need to consider these industry trends to enhance its environmental responsibility and stakeholder engagement.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Laborie Medical Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
